Seres Therapeutics, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
MCRB on Nasdaq
Industry
Pharmaceutical Preparations
Location
200 Sidney Street, Cambridge, Massachusetts

Insiders trading volume in the past year

Seres Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Nutritional Health LTP Fund General Partner LLC 10%+ Owner $31.7M Jul 5, 2022
Flagship Pioneering Fund VII General Partner LLC 10%+ Owner $7.86M Jul 5, 2022
David Arkowitz Chief Financial Officer $240K -$9.74K -3.9% Feb 14, 2024
Eric D. Shaff CEO and President, Director $188K -$28.4K -13.1% Aug 15, 2024
Thomas DesRosier Chief Legal Officer and EVP $127K -$11.4K -8.25% Aug 15, 2024
David S. Ege Executive Vice President and Chief Technology Officer $97.3K -$12.9K -11.7% Aug 15, 2024
Teresa L. Young EVP, Chief Commercial & Strategy Officer $89.6K -$35.4K -28.3% Aug 15, 2024
Matthew R. Henn Chief Scientific Officer and EVP $80.1K -$11.4K -12.4% Aug 15, 2024
Paula Cloghessy Executive Vice President, Chief People Officer $71.8K -$3.92K -5.17% Oct 27, 2023
Meryl Zausner Director $42.9K Jul 5, 2022
Lisa von Moltke Executive Vice President and Chief Medical Officer $42.6K -$12.2K -22.2% Aug 15, 2024
Richard N. Kender Director Apr 4, 2024
Stephen Berenson Director Jul 1, 2024
Paul Biondi Director Apr 4, 2024
Willard H. Dere Director Apr 4, 2024
Dennis A. Ausiello Director Jul 1, 2024
Gregory Behar Director Jun 22, 2023
Marella Thorell EVP and Chief Financial Officer Mar 25, 2024
Claire Fraser Director Apr 4, 2024
Kurt Graves Director Jul 1, 2024

Recent Insider Transactions by Companies or Individuals for Seres Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.